SCHEMBL21396880

SCHEMBL21396880

N#Cc1c(-n2c3ccc(-c4ccccc4)cc3c3cc(-c4ccccc4)ccc32)cc(-c2cccc(-n3c4ccccc4c4ccncc43)c2)cc1-n1c2ccc(-c3ccccc3)cc2c2cc(-c3ccccc3)ccc21

nearest known ligand 0.38

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CYP11B2 P19099 2/20 0.38
KDM4E B2RXH2 1/20 0.34
ATM Q13315 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
DYRK1A Q13627 2/20 0.33
NPY5R Q15761 1/20 0.32
DHODH Q02127 1/20 0.32
PDE10A Q9Y233 1/20 0.32
PIP4K2A P48426 4/20 0.32
CDK4 P11802 1/20 0.32
CDK6 Q00534 1/20 0.32
MAPT P10636 1/20 0.31
TSPO P30536 1/20 0.31
GSK3B P49841 1/20 0.31
KCNH2 Q12809 1/20 0.31
CYP11B1 P15538 1/20 0.31
MAOA P21397 1/20 0.31
SQOR Q9Y6N5 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21397076 1.00 CYP11B2 (0.38) CYP11B2KDM4EATML3MBTL1DYRK1A
SCHEMBL21396832 0.98 CYP11B2 (0.34) CYP11B2KDM4EDYRK1ADHODHPDE10A
SCHEMBL21396825 0.94 CYP11B2 (0.38) CYP11B2KDM4EATML3MBTL1DYRK1A
SCHEMBL21396874 0.94 CYP11B2 (0.39) CYP11B2KDM4EATML3MBTL1DYRK1A
SCHEMBL21396875 0.92 CYP11B2 (0.36) CYP11B2KDM4EDYRK1ADHODHPDE10A
SCHEMBL21378046 0.90 CYP11B2 (0.39) CYP11B2KDM4EL3MBTL1PIP4K2AMAPT
SCHEMBL21378021 0.88 CYP11B2 (0.38) CYP11B2CDK4CDK6CYP11B1MAOA
SCHEMBL15945601 0.88 ATM (0.44) KDM4EATML3MBTL1DYRK1ANPY5R
SCHEMBL21481249 0.88 ATM (0.44) KDM4EATML3MBTL1DYRK1ANPY5R
SCHEMBL19909124 0.87 KDM4E (0.42) CYP11B2KDM4EATML3MBTL1DYRK1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190292181-A1 COMPOSITION OF MATTER FOR USE IN ORGANIC LIGHT-EMITTING DIODES Kyulux North America, Inc. 2019-09-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190292181-A1 COMPOSITION OF MATTER FOR USE IN ORGANIC LIGHT-EMITTING DIODES CRY2, SLCO1B3, NDUFV3 CYP11B2 1221/4885KDM4E 4364/4885ATM 1817/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.